RAHONIE PERSAUD EVANS: Open Payments
NPI 1861625089 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 31 payments from 9 companies in 2025. Trend: 2023 $370 · 2024 $391 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $311 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Supernus Pharmaceuticals, Inc. | 3 | $81 |
| ABBVIE INC. | 3 | $69 |
| Coherus Oncology, Inc. | 1 | $37 |
| Phadia US Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, Jornay PM, Qelbree, REXULTI, VRAYLAR, Udenyca, ABILIFY ASIMTUFII, ImmunoCAP.
Industry payments across FL — which companies pay providers there.
